Trials / Conditions / Complicated Skin and Skin Structure Infections
Complicated Skin and Skin Structure Infections
5 registered clinical trials studyying Complicated Skin and Skin Structure Infections.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Completed | Telavancin Observational Use Registry (TOUR) NCT02288234 | Cumberland Pharmaceuticals | — |
| Completed | Efficacy and Safety Study of JNJ-32729463 for Treating Complicated Skin and Skin Structure Infections Compared NCT01128530 | Furiex Pharmaceuticals, Inc | Phase 2 |
| Completed | Study Evaluating The Safety And Effectiveness In Subjects With Tigecycline Treatment NCT01072539 | Pfizer | — |
| Terminated | Study of Daptomycin Safety and Efficacy for Complicated Skin and Skin Structure Infections (cSSSI) and Bactere NCT01104662 | Cubist Pharmaceuticals LLC, a subsidiary of Merck & Co., Inc. (Rahway, New Jersey USA) | Phase 4 |
| Completed | Post-Marketing Study Of The Safety Of Tygacil (Tigecycline) NCT00683332 | Pfizer | — |